(KPTI) Karyopharm Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Karyopharm Therapeutics | (KPTI) share price targets
Complete technical analysis of Karyopharm Therapeutics (KPTI) by charts plus indicators, forecast predictions and share price targets for Karyopharm Therapeutics (KPTI)
Karyopharm Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-02-28 View latest technical analysis
10 day averaged volume of Karyopharm Therapeutics is 1121920
Date | Daily Closing Price | Open | High | Low | Volume |
28 Fri Feb 2025 | 7.95 | 8.70 | 8.70 | 7.89 | 0.108 times |
27 Thu Feb 2025 | 8.35 | 9.48 | 10.38 | 8.34 | 0.187 times |
26 Wed Feb 2025 | 9.83 | 8.78 | 10.25 | 8.30 | 0.482 times |
25 Tue Feb 2025 | 0.57 | 0.60 | 0.60 | 0.56 | 1.186 times |
24 Mon Feb 2025 | 0.60 | 0.54 | 0.63 | 0.51 | 2.381 times |
21 Fri Feb 2025 | 0.60 | 0.60 | 0.63 | 0.59 | 0.943 times |
20 Thu Feb 2025 | 0.61 | 0.61 | 0.64 | 0.60 | 0.505 times |
19 Wed Feb 2025 | 0.60 | 0.62 | 0.62 | 0.53 | 2.023 times |
18 Tue Feb 2025 | 0.63 | 0.63 | 0.65 | 0.62 | 0.956 times |
14 Fri Feb 2025 | 0.62 | 0.63 | 0.63 | 0.59 | 0.706 times |
Although my analysis for stock is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 8.2, for a target of 4.7 or 1.83
Share price targets for Karyopharm Therapeutics (KPTI)
Target Type | Value |
Downside Target | 0.51 |
Downside Target | 0.53 |
Downside Target | 0.58 |
Downside Target | 0.60 |
Downside Target | 0.65 |
Downside Target | 0.67 |
Downside Target | 0.69 |
Downside Target | 0.72 |
Downside Target | 0.74 |
Downside Target | 0.80 |
Downside Target | 0.83 |
Downside Target | 1.02 |
Downside Target | 1.13 |
Upside Target | 10.38 |
Intraday share price targets for Karyopharm Therapeutics (KPTI)
Target Type | Value |
Downside Intraday Target | 2.18 |
Downside Intraday Target | -3.59 |
Upside Intraday Target | 12.05 |
Upside Intraday Target | 16.15 |
Downside Intraday Target | 6.28 |
Weekly technical analysis of Karyopharm Therapeutics (KPTI)
Date | Weekly Closing Price | Open | High | Low | Volume |
28 Fri Feb 2025 | 7.95 | 0.54 | 10.38 | 0.51 | 0.982 times |
21 Fri Feb 2025 | 0.60 | 0.63 | 0.65 | 0.53 | 1.1 times |
14 Fri Feb 2025 | 0.62 | 0.65 | 0.67 | 0.58 | 1.136 times |
07 Fri Feb 2025 | 0.63 | 0.62 | 0.69 | 0.60 | 1.363 times |
31 Fri Jan 2025 | 0.62 | 0.69 | 0.72 | 0.62 | 0.858 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Karyopharm Therapeutics (KPTI)
Date | Monthly Closing Price | Open | High | Low | Volume |
28 Fri Feb 2025 | 7.95 | 0.62 | 10.38 | 0.51 | 1.124 times |
31 Fri Jan 2025 | 0.62 | 0.70 | 0.83 | 0.61 | 0.775 times |
31 Tue Dec 2024 | 0.68 | 0.77 | 0.80 | 0.58 | 1.618 times |
26 Tue Nov 2024 | 0.88 | 0.99 | 1.02 | 0.75 | 0.608 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Karyopharm Therapeutics (KPTI)
Price action analysis of Karyopharm Therapeutics ( (KPTI) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Karyopharm Therapeutics ( (KPTI) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Karyopharm Therapeutics ( (KPTI) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Karyopharm Therapeutics ( (KPTI) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Karyopharm Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Karyopharm Therapeutics in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Karyopharm Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Karyopharm Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Karyopharm Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.31 and Karyopharm Therapeutics (KPTI) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Karyopharm Therapeutics (KPTI) stock. Volume based technical analysis of Karyopharm Therapeutics (KPTI) stock is negative.
Karyopharm Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Karyopharm Therapeutics ( (KPTI) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Karyopharm Therapeutics ( (KPTI) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Karyopharm Therapeutics ( (KPTI) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Karyopharm Therapeutics ( (KPTI) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Karyopharm Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Karyopharm Therapeutics in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Karyopharm Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Karyopharm Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Karyopharm Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.31 and Karyopharm Therapeutics (KPTI) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Karyopharm Therapeutics (KPTI) stock. Volume based technical analysis of Karyopharm Therapeutics (KPTI) stock is negative.
Karyopharm Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.